July 21, 2020 / 8:28 AM / 21 days ago

S.Korea's SK Bioscience in deal with AstraZeneca on vaccine

SEOUL, July 21 (Reuters) - SK Bioscience has signed a letter of intent with Britain’s AstraZeneca for global production of its experimental COVID-19 vaccine, the South Korean company said on Tuesday.

South Korea’s health ministry will also participate in the cooperation, the company said in a statement. (Reporting by Sangmi Cha; editing by Jason Neely)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below